Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa A Gray

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|November 12, 2015
A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer CellsMelissa A Gray, Ran N Tao, Sandra M DePorter, et al.
Molecular Biosystems|November 5, 2013
Mutagenesis modulates the uptake efficiency, cell-selectivity, and functional enzyme delivery of a protein transduction domainSandra M DePorter, Irene Lui, Virginia J Bruce, et al.
Nature Chemistry|July 24, 2023
Chemical generation of checkpoint inhibitory T cell engagers for the treatment of cancerPeter A Szijj, Melissa A Gray, Mikaela K Ribi, et al.
Nature Communications|October 25, 2019
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase actionPedro Bule, Léa Chuzel, Elena Blagova, et al.
The Journal of Biological Chemistry|April 28, 2023
Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activityMichael J Hollander, Stacy A Malaker, Nicholas M Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2020
DNA origami protection and molecular interfacing through engineered sequence-defined peptoidsShih-Ting Wang, Melissa A Gray, Sunting Xuan, et al.
Journal of the American Chemical Society|August 3, 2019
Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar PairsJunwon Choi, Lauren J S Wagner, Suzanne B P E Timmermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7Simon Wisnovsky, Leonhard Möckl, Stacy A Malaker, et al.
Nature Chemical Biology|August 19, 2020
Targeted glycan degradation potentiates the anticancer immune response in vivoMelissa A Gray, Michal A Stanczak, Natália R Mantuano, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Ratiometric transcriptional activation by protein degradationMelissa A Gray, Katelyn L Randal, Jennifer A Co, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|November 12, 2015
A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer CellsMelissa A Gray, Ran N Tao, Sandra M DePorter, et al.
Molecular Biosystems|November 5, 2013
Mutagenesis modulates the uptake efficiency, cell-selectivity, and functional enzyme delivery of a protein transduction domainSandra M DePorter, Irene Lui, Virginia J Bruce, et al.
Nature Chemistry|July 24, 2023
Chemical generation of checkpoint inhibitory T cell engagers for the treatment of cancerPeter A Szijj, Melissa A Gray, Mikaela K Ribi, et al.
Nature Communications|October 25, 2019
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase actionPedro Bule, Léa Chuzel, Elena Blagova, et al.
The Journal of Biological Chemistry|April 28, 2023
Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activityMichael J Hollander, Stacy A Malaker, Nicholas M Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2020
DNA origami protection and molecular interfacing through engineered sequence-defined peptoidsShih-Ting Wang, Melissa A Gray, Sunting Xuan, et al.
Journal of the American Chemical Society|August 3, 2019
Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar PairsJunwon Choi, Lauren J S Wagner, Suzanne B P E Timmermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7Simon Wisnovsky, Leonhard Möckl, Stacy A Malaker, et al.
Nature Chemical Biology|August 19, 2020
Targeted glycan degradation potentiates the anticancer immune response in vivoMelissa A Gray, Michal A Stanczak, Natália R Mantuano, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Ratiometric transcriptional activation by protein degradationMelissa A Gray, Katelyn L Randal, Jennifer A Co, et al.
Pageof 2